January 1, 2009
Pre-Screening Effective In Reducing Otolaryngic Surgical Infection Rates
Pre-operative screening of patients for methicillin-resistant staphylococcus aureus (MRSA) may be an effective way to reduce infection rates following otolaryngic surgeries, according to new research published in the January 2009 issue of Otolaryngology "“ Head and Neck Surgery.
The study, conducted by researchers at the Massachusetts Ear & Eye Infirmary, is the first to review otolaryngic procedures, and reviewed the medical records of 420 patients. Of the 241 non-pre-screened patients during a one-year period, nine patients had staphylococcus aureus infections, including two post-operative MRSA surgical site infections. Of the 179 patients pre-screened using a nasal swab, 24 patients were identified as having staphylococcus aureus colonies, and underwent pre-operative treatment; none of these patient cases resulted in post-operative MRSA infections.
Due to particular concerns about MRSA infections in otolaryngic surgeries, the authors recommend further, larger studies, with an emphasis on high-risk patients, including those with multiple comorbidities, head and neck cancer patients, patients receiving implanted devices, and patients with prior hospitalizations or multiple courses of antibiotics.
Otolaryngology "“ Head and Neck Surgery is the official scientific journal of the American Academy of Otolaryngology "“ Head and Neck Surgery Foundation (AAO-HNSF) and the American Academy of Otolaryngic Allergy (AAOA). The study's authors are Sara L. Richer, MD, and Barry L. Wenig, MD, MPH.
On the Net: